Cardinal Health, Inc.

US$271.72As of Sun 8 Nov 2026, 12:00 UTC
NYSE:CAHHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 17.90%
Div yield 0.76%
ROE —
Medical Distribution
Beta (5Y) 0.52
PE TTM 35.18
TSR TTM 43.78%
Mkt cap US$62.80B
ROIC 20.50%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$294
8.32%
(79.54%)
Hold 12|1|9|12|9
2Q26
3Q26
4Q26
1Q27
Earnings per share$
4.57
5.07
5.64
6.31
13.30%
23.07%
30.13%
43.85%
Revenue$B
3.558
3.641
3.798
3.752
5.89%
3.05%
5.66%
6.85%
Peers (US$62.80B)
Cap (US$)
PE
122.5B
27.22x
63.65B
18.58x
9.512B
23.58x
52.09B
42.18x
Capital
TTM
5Y
10Y
Leveragex
0.597
0.015
—
EBIT/Intx
0.822
0.227
0.197
Own earn%
26.00
6.07
13.82
Sh yield%
29.03
38.28
38.79
Owners
Insiders/Inst%
6.92
62.83
Short interest%
5.35
SBC / revenue%
1.52
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
2–10
$1 testx
0.0
Incr. ROIC%
33

Cardinal Health, Inc. distributes branded, generic, specialty and over-the-counter pharmaceutical products and manufactures and distributes medical, surgical and laboratory products, including gloves, syringes, and procedure kits, for hospitals, pharmacies, surgery centers, laboratories, physician offices and home patients in the United States and internationally, and provides pharmacy management and supply chain services.